Edgewise Therapeutics, Inc.
EWTX
Peringkat dalam Saham
#3873
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing... Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Harga Saham
$39.70
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$4.27B
Perubahan (1 hari)
-0.12%
Perubahan (1 tahun)
166.64%
Negara
US
Perdagangan Edgewise Therapeutics, Inc. (EWTX)
Kategori
Healthcare
Riwayat harga saham Edgewise Therapeutics, Inc. (EWTX)
Harga penutupan tertinggi: $38.97 pada 2026-10-01
Harga penutupan terendah: $32.43 pada 2021-03-01
Harga penutupan terendah: $32.43 pada 2021-03-01
Riwayat harga saham Edgewise Therapeutics, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 38.00% |
| 2025 | -20.97% |
| 2024 | 268.96% |
| 2023 | -1.80% |
| 2022 | -51.10% |
| 2021 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.09 | -4.30% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
